1McKelvie RS,Yusuf S, Pericak D, et al. Comparison of candesartan,enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD)pilot study[J]. Circulation, 1999,100:1056-1064.
2Sunil Mankad, Thomas A, Nathanel R, et al. Combined angiotensin Ⅱ receptor antagonism and angiotensin-converting enzyme inhibition further attenuates postinfarction left ventricular remodeling [J]. Circulation, 2001,103: 2845-2850.
3Cheuk-Man Yu,George L, Kevin W, et al. Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction[J]. J Am Coil Cardiol,2001,38:1207-1215.
5Georg Nickenig. The AT1-type angiotensin receptor in oxidative stress and atherogenesis[J]. Circulation, 2002,105:393-396.
6Hollenberg NK. Pathways for angiotension Ⅱ generation in intact human tissue[J]. Hypertension, 1998,32:387-392.
7Wharton J, Morgan K, Rutherford RA, et al. Differential distribution of angiotensin AT2 receptors in the normal and failing human heart[J]. J Pharmacol Exp Ther, 1998,284:323-336.
8Sunghou Lee, Christopher M, Sunil Mankad, et al. Combined angiotensin converting enzyme inhibition and angiotensin AT1 receptor blockade up-regulates myocardial AT2 receptors in remodeled myocardium post-infarction[J]. Cardiovasc Res,2001,51 : 131-139.
9Vankats JP. Angiotensin converting enzyme inhibition and angiotensin Ⅱ type 1 receptor blockade prevent cardiac remoeling in pigs after myocardial infarction; role of tissue angiotensin[J]. Circulation,2000,102:1556-1563.
10Emanueli C. Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia [J].Circulation,2001,103:125-132.
二级参考文献4
1Gomez Sanchez E P，Steroids，1996年，6卷，184页
2Ikeda U，Eur J Pharmacol，1995年，290卷，69页
3Junji N，Biochem Biophys Res Commun，1992年，188卷，719页
4Hum SA, Abraham WT, Chin MH,et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society[J]. Circulation.2005,112(12) :e154-235.
5Eichhom EJ, Bristow MR. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure [ J ]. Circulation, 1996,94 (9) :2285-2296.
6Bristow MR. Why does the myocardium fail? Insights from basic science[ J ]. Lancet, 1998,352 ( Suppl 1 ) : SI8-14.
